Standout Papers

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Lar... 2012 2026 2016 2021 470
  1. Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (2012)
    Tina Green, Ken H. Young et al. Journal of Clinical Oncology

Citation Impact

22 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
3 intermediate papers

Works of Michael Møller being referenced

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
2012 Standout
Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A
2000

Author Peers

Author PFM Oncology Genetics Last Decade Papers Cites
Michael Møller 1573 1263 1019 154 4.1k
H. M�ntefering 15 30 1 11 310
Bernard Rosen 1 2 21 555
Kari Pulfer 3 5 2 26 606
Yeong‐Jiunn Jang 1 28 608
Markus Sormaala 5 1 2 14 268

All Works

Loading papers...

Rankless by CCL
2026